Bain Capital Life Sciences Opportunities III, LP 13D and 13G filings for Century Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:30 pm Sale | 2025-09-30 | 13G | Century Therapeutics, Inc. IPSC | Bain Capital Life Sciences Opportunities III, LP | 3,538,609 4.100% | -1,781,722 (-33.49%) | Filing |
| 2024-04-25 4:48 pm Purchase | 2024-04-15 | 13G | Century Therapeutics, Inc. IPSC | Bain Capital Life Sciences Opportunities III, LP | 5,320,331 6.600% | 5,320,331 (New Position) | Filing |